– Advertisement –

Study Published in 2016 Shows Common Supplement L-Lysine Effective Against Coronaviruses

by | Mar 27, 2020 | Health, News | 0 comments

💡We need your support. As big tech continues its crackdown on conservative blogs, our days on these platforms are numbered. Go Ad-Free plus get Exclusive Member-Only content by subscribing to us on Substack!

While the world is in panic amid the current outbreak of SARS-CoV-2 Coronavirus (COVID-19), the pharmaceutical industry is racing to find a cure that can be patented and sold for big profits. But is there already an effective treatment available to help combat the deadly effects of the novel coronavirus out of China?

One study published in the Journal of Antivirals and Antiretrovirals suggests maybe. The published study describes the results of a test of combination of a couple of different over-the-counter supplements including D, L-lysine acetylsalicylate and glycine (Aspirin).

L-Lysine is a common amino acid found in nutrition and supplement stores around the globe and is readily available in many forms. Since L-Lysine is a naturally-occurring substance, the substance itself cannot be patented. Therefore there is little to no profit-motivation for pharmaceutical companies to fund clinical trials and promote these products. This is why you will often find disclaimers on the labels stating that the FDA has not validated the effectiveness of these supplements or that they are not intended to cure any disease. Essentially, it’s just legal mumbo-jumbo.

But this particular study has not made widespread rounds in the blogosphere or social media yet during this crisis. The study, however, suggests that L-Lysine could possibly be a candidate for combating this disease.

Join Us and Get These Perks:

✅ No Ads in Articles
✅ Access to Comments and Discussions
✅ Community Chats
✅ Full Article and Podcast Archive
✅ The Joy of Supporting Our Work 😉

The study reads,

In conclusion, we were able to demonstrate that LASAG inhibits virus-induced NF-κB activity, which might be connected to the antiviral effect against CoV, including the impaired formation of RTCs and/or DMVs in CoV-infected cells, leading to reduced viral RNA production and consequently decreased production of viral proteins, resulting in an overall diminished virus titre.

Of course, this was published 4 years ago and did not take into account some of the differences between the more common coronaviruses and the one the world is dealing with right now. The study does, however, seem to suggest that it was effective in treating other deadly coronaviruses such as the 2003 SARS-CoV and the 2016 MERS-CoV outbreaks. It could be worth looking into and, in conclusion, it probably wouldn’t hurt.

The Dissenter is primarily supported by its readers. The best way to support us is to subscribe to our members-only site where you will receive all of our content ad-free, plus you will get member-only exclusive content.

Or you can make a one-time or recurring donation using the box below. (Note, the donation box below is not for memberships, but for donations. For memberships, use the button above.) For all other donor or supporter inquiries, please reach out to jeff@disntr.com.

- Advertisement -


- Advertisement -



Follow Us

- Advertisement -

You Might Also Like…

- Advertisement -

Want to go ad-free with exclusive content? Subscribe today.

This will close in 0 seconds